3S53 | Hydrolase Hydrolase Inhibitor | date | May 20, 2011 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Hiv-1 Protease Triple Mutants V32i, I47v, V82i With Antivira Darunavir In Space Group P212121 | ||||||||||||||
authors | Y.F.Tie, Y.F.Wang, I.T.Weber | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Protease Chain: A, B Ec: 3.4.23.16 Engineered: Yes Mutation: Yes |
Organism_scientific: Human Immunodeficiency Virus 1 Organism_taxid: 11676 Gene: Pol Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21 (De3) Expression_system_vector_type: Plasmid Expression_system_plasmid: Pet11a | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.50 Å | ||||||||||||
ligand | 017, IOD, PO4 | enzyme | Hydrolase E.C.3.4.23.16 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors., Tie Y, Wang YF, Boross PI, Chiu TY, Ghosh AK, Tozser J, Louis JM, Harrison RW, Weber IT, Protein Sci. 2012 Mar;21(3):339-50. doi: 10.1002/pro.2019. Epub 2012 Jan 24. PMID:22238126 |
Data retrieval |
View 3S53 in 3D |
Visual 3D analysis of 3S53 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3S53 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |